All Articles

Obstetrics, Gynecology, & Neonatal

7 mins

Laborie Acquires the JADA® System for Rapid Postpartum Hemorrhage Control, Expanding Obstetrics Portfolio

Laborie Medical Technologies Corp (“Laborie”) today announced the closing of…

Written By Laborie Medical Technologies

General News

4 mins

Laborie Announces First Procedures in ENDURE 1 Study with the Optilume® Ureteric Drug-Coated Balloon

Written By laborie

General News

4 mins

Laborie Appoints Chris Smith as Chief Executive Officer

Laborie Medical Technologies Corp., a global leader in medical technology,…

Written By Ashley Brindamour

Urology & Urogynecology

4 mins

Laborie’s Optilume® Drug-Coated Balloon for Stricture Secures Coverage from BCBS of Michigan

Effective July 1, 2025, Blue Cross Blue Shield of Michigan…

Written By Ashley Brindamour

Urology & Urogynecology

4 mins

Three-Year Data from ROBUST III Confirms Long-Term Durability of Optilume® Drug-Coated Balloon for Recurrent Urethral Strictures

Laborie Medical Technologies Corp. (Laborie), a global leader in diagnostic…

Written By Rachel Pearce

Urology & Urogynecology

3 mins

Optilume Drug-Coated Balloon Shows Long-Term Efficacy for Urethral Strictures: Five-Year Data Published in the Journal of Urology

Written By rharmond

General News |

Urology & Urogynecology

3 mins

Optilume® BPH Catheter System Issued Category 1 CPT Code by American Medical Association

Written By mburgers

Obstetrics, Gynecology, & Neonatal

5 mins

Laborie Medical Technologies to Invest in Medical Technology Start-Up Novocuff 

Laborie announced its investment in Novocuff, an early-stage medical technology…

Written By Rachel Pearce